January 15, 2020

IntelGenx Receives Authorization for Alzheimer’s Treatment Trial

Health Canada has issued a No Objection Letter in response to IntelGenx’s amended application for its ongoing trial in patients...
January 13, 2020

IntelGenx Confirms Cannabis-Infused Film Release in Q1 2020

IntelGenx confirmed that its cannabis-infused oral film, VersaFilm, is on track to be released commercially in Q1 2020.
October 9, 2019

IntelGenx Receives DSMB Recommendation for Phase 2a Trial

The Data Safety Monitoring Board completed its analysis of the company's Montelukast VersaFilm Phase 2a clinical trial of Alzheimer's Disease.
September 4, 2019

IntelGenx Partners with Tilray to Create Cannabis-infused Oral Strips

One pharmaceutical company is giving consumers the chance to experience the effects of cannabis in a new form: oral strips.